The noac storyline.
09.2023
Delivery of the first ExoRobot noac
Declaration of Conformity
CE-Zeichen nach MDR
08.2023
08.2023
Start serial production
Product launch
11.2022
08.2022
Go live with QMS according to ISO 13485
Conclusion of production contract
07.2022
05.2022
Silent participation with MBG, venture capital Reutlingen, sCapital Tübingen over €800,000
Messe Leipzig (German Surgeons Congress)
04.2022
02.2022
1st trade fair appearance in Nuremberg
(Federal Congress of Surgery)
Completion of prototype P/3
11.2021
09.2021
Seed investment round, second closing, investors PrimeCrowd and The One Group
Presentation of design draft by Weinberg and Ruf
06.2021
First Human Trial at UK Tübingen
02.2021
Minimum viable product with electrification
01.2021
Patent granted "on our core" of the product
12.2020
prototype 2
08.2020
Expansion of the team with shareholder Claudia Sodha (CFO)
04.2020
Development and production of face shields
for clinics and practices nationally/internationally
02.2020
Top 50 startups in Germany
12.2019
Presentation of Darboven advancement prize 3rd place
10.2019
Admission partner Prof. Dr. Martin Schuhman
+ PD Dr. Felix Neunhoeffer
07.2019
prototype 1
01.2019
Founding of the GmbH Sabrina Hellstern
with Alexander Strobel & Harald Rager
07.2018
08.2021
Seed Investment Round, First Closing, Investor Venture League
04.2021
PCT filing
01.2021
divisional application
01.2021
Registration of trademark application noac – not only a chair
12.2020
Pre-seed financing by private investor and L-Bank BW
06.2020
Prototype Evolution B
03.2020
patent application
01.2020
Proof of effectiveness: randomized crossover study of
Neurology and occupational medicine at the University Hospital in Tübingen
11.2019
Prototype Evolution A
07.2019
Top 10 in the medical industry business plan competition
05.2019
Founder's Award Baden-Württemberg 2nd place
01.2019
Development of the team with the engineers Strobel & Rager
That is why Hellstern medical was founded:
